Shengnan Ren

发表

Recent Advances in the Pharmacological Activities of Dioscin

Longfei Yang, Shengnan Ren, Fei Xu, 2019, BioMed research international.

Ti3C2-MXene-assisted signal amplification for sensitive and selective surface plasmon resonance biosensing of biomarker

Shengnan Ren, Wen Wu, Qiong Wu, 2021, Chinese Journal of Analytical Chemistry.

The expression, function, and utilization of Protamine1: a literature review

Shengnan Ren, Xuebo Chen, Xuedong Fang, 2021, Translational cancer research.

Protamine 1 as a secreted colorectal cancer-specific antigen facilitating G1/S phase transition under nutrient stress conditions

Yongli Dong, Shengnan Ren, Ye Feng, 2023, Cellular Oncology.

Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)

Shengnan Ren, Mengyuan Li, Xuedong Fang, 2023, International journal of oncology.

Laparoscopic transanal pull-through total mesorectal excision with double stapling technique for low/ultra-low rectal cancer

X. Fang, Shengnan Ren, Ying Shi, 2013 .

Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membrane.

Guizhen Zhang, Xuedong Fang, X. Fang, 2016, Oncology letters.

Re-sensitization of radiation resistant colorectal cancer cells to radiation through inhibition of AMPK pathway.

F. Ji, Shengnan Ren, Zhuo Liu, 2016, Oncology letters.

Recent Advances in the Pharmacological Activities of Dioscin

Longfei Yang, Shengnan Ren, Fei Xu, 2019, BioMed research international.